Contract award notice
Results of the procurement procedure
Section I: Contracting
authority
I.1) Name and addresses
The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health)
2nd Floor, Rutland House
Runcorn
WA7 2ES
UK
E-mail: sarah.blackman@dh.gsi.gov.uk
NUTS: UK
Internet address(es)
Main address: https://cmu.bravosolution.co.uk
Address of the buyer profile: https://cmu.bravosolution.co.uk
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
NHS National Framework Agreement for NHS Pharmaceutical Products.
Reference number: CM/PHG/15/5467
II.1.2) Main CPV code
33600000
II.1.3) Type of contract
Supplies
II.1.4) Short description
NHS Pharmaceutical Products:
Reference number: CM/PHG/15/5467.
Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 48 months.
Potential periods of call-offs under the framework agreement:
Oral Products (100 %);
All Regions: 1.3.2017 to 28.2.2019 (24 months).
Hospital only Products (33 %);
All Regions: 1.3.2017 to 30.6.2018 (16 months).
The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England.
The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Document 10 in the Invitation To Offer Documents for the list of Purchasing Points.
II.1.6) Information about lots
This contract is divided into lots:
Yes
II.1.7) Total value of the procurement
Value excluding VAT:
310 000 000.00
GBP
II.2) Description
Lot No: The tender comprised of the following Lots, DCE, DSW, DLS, DNE, DLN, DNW
II.2.1) Title
NHS Pharmaceutical Products
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
See below.
II.2.4) Description of the procurement
NHS Framework Agreement for NHS Pharmaceutical Products.
Reference number: CM/PHG/15/5467
Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 48 months.
Potential periods of call-offs under the framework agreement:
Oral Products (100 %)
All Regions: 1.3.2017 to 28.2.2019 (24 months).
Hospital Only Products (33 %).
All Regions: 1.3.2017 to 30.6.2018 (16 months).
II.2.5) Award criteria
Quality criterion: The most economically advantageous tender in terms of the criteria stated in the specifications, in the invitation to tender or to negotiate or in the descriptive document
/ Weighting: See Over
Cost criterion: The most economically advantageous tender in terms of the criteria stated in the specifications, in the invitation to tender or to negotiate or in the descriptive document
/ Weighting: See Over
II.2.11) Information about options
Options:
Yes
Description of options:
Dates detailed below with options to extend up to a maximum of 48 months.
Oral Products (100 %).
All Regions: 1.3.2017 to 28.2.2019 (24 months).
Hospital Only Products (33 %).
All Regions: 1.3.2017 to 30.6.2018 (16 months).
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
Lot Description:
DCE — Central;
DSW — South Central and South West;
DLS — South East and South London;
DNE — North East and Yorkshire;
DLN — Eastern and North London;
DNW — North West.
Lot No: All as detailed in Lot 1 and in the Invitation to Offer documents
II.2.1) Title
NHS Pharmaceutcals Products
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
Please see below.
II.2.4) Description of the procurement
NHS Framework Agreement for NHS Pharmaceutical Products.
Reference number: CM/PHG/15/5467
Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 48 months.
Potential periods of call-offs under the framework agreement:
Oral Products (100 %).
All Regions: 1.3.2017 to 28.2.2019 (24 months).
Hospital Only Products (33 %).
All Regions: 1.3.2017 to 30.6.2018 (16 months).
II.2.5) Award criteria
Quality criterion: The most economically advantageous tender in terms of the criteria stated in the specifications, in the invitation to tender or to negotiate or in the descriptive document
/ Weighting: See Over
Cost criterion: The most economically advantageous tender in terms of the criteria stated in the specifications, in the invitation to tender or to negotiate or in the descriptive document
/ Weighting: See Over
II.2.11) Information about options
Options:
Yes
Description of options:
Dates detailed below with options to extend up to a maximum period of 28 months:
Oral Products (100 %).
All Regions: 1.3.2017 to 28.2.2019 (24 months).
Hospital Only Products (33 %).
All Regions: 1.3.2017 to 30.6.2018 (16 months).
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Restricted procedure
IV.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2016/S 143-259138
Section V: Award of contract
Lot No: 1
Contract No: CM/PHG/15/5467
Title: NHS Pharmaceutical Products
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
16/12/2016
V.2.2) Information about tenders
Number of tenders received: 103
Number of tenders received by electronic means: 103
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Please see Section IV.3
Please see Section IV.3
Please see Section IV.3
Please see Section IV.3
UK
NUTS: UK
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 310 000 000.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
Please see list of awarded suppliers at the following website:
https://www.gov.uk/contracts-finder
Specific tender URL:
https://www.contractsfinder.service.gov.uk/Notice/Manage/Basic/c295706e-135c-42c5-9435-b70b0799cb98.
VI.4) Procedures for review
VI.4.1) Review body
The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health)
Runcorn
UK
VI.5) Date of dispatch of this notice
18/01/2017